Abdula Kurkayev

Title: Abdula Kurkayev: Innovator in Cyclodextrin Research

Introduction

Abdula Kurkayev is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of lysosomal neurodegenerative diseases. His innovative work focuses on the use of chemically modified cyclodextrins, which have potential therapeutic applications.

Latest Patents

Kurkayev holds a patent for "Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases." This invention relates to the use of single isomer chemically modified cyclodextrins, specifically S-(carboxyalkyl)-thio-cyclodextrin salts, in medications aimed at preventing or treating lysosomal storage diseases. The patent details the use of isomer-pure, single isomer hexakis-S-(carboxyalkyl)-hexathio-alpha-cyclodextrin sodium salts, heptakis-S-(carboxyalkyl)-heptathio-beta-cyclodextrin sodium salts, and octakis-S-(carboxyalkyl)-octathio-gamma-cyclodextrin sodium salts.

Career Highlights

Throughout his career, Abdula Kurkayev has worked with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. His expertise in cyclodextrin chemistry has positioned him as a key figure in the development of innovative treatments for complex diseases.

Collaborations

Kurkayev has collaborated with notable professionals in his field, including István Puskás and Lajos Szente. These partnerships have contributed to the advancement of research in cyclodextrin applications.

Conclusion

Abdula Kurkayev's work in the field of cyclodextrin derivatives showcases his commitment to advancing medical science. His innovative patent holds promise for the treatment of lysosomal neurodegenerative diseases, highlighting the importance of research in this area.